Filing Details
- Accession Number:
- 0001553878-13-000021
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-02 17:32:28
- Reporting Period:
- 2013-07-01
- Filing Date:
- 2013-07-02
- Accepted Time:
- 2013-07-02 17:32:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1514291 | Michael Mason | 300 3Rd Street Cambridge MA 02142 | Vp, Finance And Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-07-01 | 12,000 | $21.35 | 19,847 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-07-01 | 12,000 | $32.00 | 7,847 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-07-01 | 15,000 | $22.75 | 22,847 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-07-01 | 15,000 | $32.00 | 7,847 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-07-01 | 12,000 | $0.00 | 12,000 | $21.35 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-07-01 | 15,000 | $0.00 | 15,000 | $22.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-12-09 | No | 4 | M | Direct | |
| 0 | 2016-12-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,821 | Indirect | By Managed Account |
Footnotes
- The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013.
- The reporting person owns 1,821 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- The stock option vests as to 25% of the shares on the first anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three-month period thereafter.
Billionaire Hedge Funds
